Pricing Log in Create free account

Biorestorative Therapies, Inc. (BRTX) vs Purple Biotech Ltd. Sponsored ADR (PPBT)

Biorestorative Therapies, Inc. and Purple Biotech Ltd. Sponsored ADR are both Biotechnology companies. Biorestorative Therapies, Inc. and Purple Biotech Ltd. Sponsored ADR are of similar size ($2.0M and $2.0M). Purple Biotech Ltd. Sponsored ADR has the higher net margin (0.00% vs −3,089.3%) and the lower return on invested capital (−290.3% vs 0.00%). Across the 14 metrics below, Purple Biotech Ltd. Sponsored ADR leads on 9 and Biorestorative Therapies, Inc. on 5.

Valuation

Metric BRTX PPBT Biotechnology median
P/E n/m n/m 8.50
P/S 3.76 n/m 9.71
P/B 0.45 0.10 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.15 0.16 0.64
EV/Sales (5.74) n/m 9.21
Earnings yield (1,407.89%) (4,315.08%) (33.15%)
Free cash flow yield (972.97%) (643.44%) (25.50%)

Profitability

Metric BRTX PPBT Biotechnology median
Gross margin 92.09% 0.00% 65.16%
Operating margin (3,974.66%) 0.00% 0.00%
Net margin (3,089.30%) 0.00% 0.00%
Free cash flow margin (3,302.04%) 0.00% 0.00%
Return on equity (241.50%) (110.67%) (56.36%)
Return on assets (147.75%) (100.91%) (48.04%)
Return on invested capital 0.00% (290.25%) 0.00%

Growth

Metric BRTX PPBT Biotechnology median
Revenue growth (TTM) (8.47%) — 6.02%
EPS growth (last fiscal year) (36.21%) (10.14%) 30.26%
Revenue growth, 5-year CAGR 36.11% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BRTX PPBT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.35 3.70 4.72
Net debt to EBITDA 0.19 0.35 0.96

Dividend

Metric BRTX PPBT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric BRTX PPBT Biotechnology median
Market cap 2.01m 1.99m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack